Jun 9, 2026 07:01AM
Jun 8, 2026 07:05AM
Jun 3, 2026 06:00AM
May 28, 2026 08:00AM
May 28, 2026 08:00AM
May 7, 2026 06:01AM
May 5, 2026 06:01AM Aclarion signs second commercial deal with Weill Cornell Medicine
Apr 30, 2026 06:01AM
Apr 28, 2026 06:00AM
Apr 8, 2026 08:02AM
Mar 24, 2026 08:04AM
Mar 24, 2026 08:00AM
Mar 19, 2026 09:26AM
Feb 5, 2026 06:00AM Aclarion says cash runway extends into 2028, ends equity facilities
Feb 3, 2026 06:01AM
Jan 13, 2026 06:01AM
Jan 9, 2026 09:10AM
Jan 8, 2026 07:00AM
Jan 6, 2026 06:00AM
Dec 4, 2025 08:02AM
Dec 2, 2025 08:01AM Aclarion names Jason Brosniak commercial director for eastern U.S.
Nov 5, 2025 06:00AM
Oct 14, 2025 06:11AM
Oct 13, 2025 06:01AM
Oct 9, 2025 06:00AM
Sep 19, 2025 03:36AM
Aug 5, 2025 06:01AM
Jul 7, 2025 04:02PM Aclarion (ACON) postpones annual shareholder meeting to July 21
May 30, 2025 05:48AM
Mar 31, 2025 07:03AM
Mar 26, 2025 07:01AM
Mar 6, 2025 09:35AM
Mar 3, 2025 07:08AM
Feb 11, 2025 07:58AM
Feb 4, 2025 07:25AM Aclarion (ACON) Announces CLARITY Trial for Nociscan Now Fully Funded
Jan 31, 2025 12:00PM
Jan 28, 2025 11:01AM
Jan 15, 2025 09:31AM
Nov 14, 2024 05:00PM
Nov 4, 2024 06:22AM
Oct 25, 2024 05:11PM
Sep 27, 2024 06:57AM Aclarion's (ACON) Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Sep 24, 2024 05:02PM
Sep 19, 2024 05:04PM
Sep 12, 2024 06:57AM
Sep 11, 2024 01:00PM
Sep 11, 2024 01:00PM
Sep 9, 2024 06:08AM
Jul 29, 2024 03:35AM Ascendiant Capital Starts Aclarion, Inc. (ACON) at Buy
Jun 20, 2024 08:10AM

416,806 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All